Padma P. Nanaware
-
- Immunotherapy and Immune Responses 7
- T-cell and B-cell Immunology 4
- Immune Cell Function and Interaction 4
-
- SARS-CoV-2 and COVID-19 Research 3
-
- Diabetes and associated disorders 2
-
- vaccines and immunoinformatics approaches 6
- Ubiquitin and proteasome pathways 3
-
- Monoclonal and Polyclonal Antibodies Research 3
- Co-authors
- Lawrence J. SternPrasanna VenkatramanMollie JurewiczArun Kumar SomavarapuScott A. ShafferNafisa BalasinorZuping HeRyan S. D’Souza
- Partner nations
- United StatesIndiaIsrael
In The Last Decade
Padma P. Nanaware
17 papers receiving 242 citations
Peers
Comparison fields: 5 of 58
- Immunology 103
- Reproductive Medicine 29
- Infectious Diseases 33
- Genetics 43
- Immunology and Allergy 9
Countries citing papers authored by Padma P. Nanaware
This map shows the geographic impact of Padma P. Nanaware's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Padma P. Nanaware with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Padma P. Nanaware more than expected).
Fields of papers citing papers by Padma P. Nanaware
This network shows the impact of papers produced by Padma P. Nanaware. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Padma P. Nanaware. The network helps show where Padma P. Nanaware may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Padma P. Nanaware, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 6 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 10 | |
| 6 | 2022 | 18 | |
| 7 | 2022 | 3 | |
| 8 | 2022 | 3 | |
| 9 | 2021 | 10 | |
| 10 | 2021 | 36 | |
| 11 | 2021 | 2 | |
| 12 | 2021 | 6 | |
| 13 | 2020 | 29 | |
| 14 | 2019 | 4 | |
| 15 | 2018 | 30 | |
| 16 | 2013 | 12 | |
| 17 | 2013 | 31 | |
| 18 | 2010 | 41 |
About Padma P. Nanaware
Padma P. Nanaware is a scholar working on Immunology, Cell Biology and Molecular Biology, having authored 18 papers that have together received 243 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), vaccines and immunoinformatics approaches (6 papers), T-cell and B-cell Immunology (4 papers), Immune Cell Function and Interaction (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Ubiquitin and proteasome pathways (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Diabetes and associated disorders (2 papers). The work is most often cited by research in Immunology (103 citations), Reproductive Medicine (29 citations) and Infectious Diseases (33 citations). Padma P. Nanaware has collaborated with scholars based in United States, India and Israel. Frequent co-authors include Lawrence J. Stern, Prasanna Venkatraman, Mollie Jurewicz, Arun Kumar Somavarapu, Scott A. Shaffer, Nafisa Balasinor, Zuping He, Ryan S. D’Souza, John Leszyk and Susan Idicula‐Thomas. Their work appears in journals such as Immunity, The Journal of Immunology and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.